Shareholders Equity: The sum of preferred and common equity items.
Avenue Therapeutics, Inc. (ATXI) had Shareholders Equity of $0.57M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.69M |
|
-- |
|
-- |
|
$0.71M |
|
$-0.71M |
|
$0.02M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.71M |
|
$-0.71M |
|
3.29M |
|
3.29M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$1.98M |
|
-- |
|
-- |
|
$1.98M |
|
$1.41M |
|
-- |
|
-- |
|
$1.41M |
|
$0.57M |
|
$0.57M |
|
|
Shareholders Equity |
$0.57M |
3.29M |
|
| Cash Flow Statement Financials | |
$-0.91M |
|
-- |
|
-- |
|
$2.85M |
|
$1.94M |
|
$-0.91M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-121.27% |
|
-121.27% |
|
-34.92% |
|
-121.27% |
|
$0.17 |
|
$-0.28 |
|
$-0.28 |
|